Delivery Order SPE2DB22D6029-SPE2DB24FU0LE
- Not listed
- This federal contract award, with a ceiling value of $24,939.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 100 MG VIALS, a specialized pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,323.36 and a period of performance through May 6, 2024. The award is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,864.71 contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, to support the DLA's Medical Supply Chain program. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2024. This appears to be a delivery order under...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,967.98 firm fixed-price contract is for the supply of 4568791017 ACTIVASE 50 MG VIALS, a medication used in medical treatments. The contract has a performance period through July 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp is a $20,520.77 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the procurement of 4563713939 ACTIVASE 100 MG VIALS. The contract has a period of performance through February 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $14,839.85 firm fixed-price delivery order is for ACTIVASE 50 MG VIALS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,141.52 Firm Fixed Price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical medical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of ACTIVASE 50 MG VIALS medical supplies. The contract, valued at $2,864.71, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, that serves as the primary vehicle for the company to deliver...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,290.62, is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of ACTIVASE 50 MG VIALS, a critical medical commodity. This contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,266.89 firm fixed price delivery order is for the supply of 4,568,373,042 units of ACTIVASE 50 MG VIALS. The contract has an ultimate completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp is a for-profit company that serves as a critical supplier of medical and pharmaceutical products...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0LEDelivery Order
This federal contract award, valued at $17,141.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ACTIVASE 100 MG VIALS pharmaceutical products. This is a firm fixed-price delivery order contract with a performance period ending on March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 3/28/24 |